This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of seizures: A Synthesis of Findings from 82 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of seizures: A Synthesis of Findings from 82 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Key Research Findings

Various studies have investigated treatments for seizures, their effectiveness, and associated risks. 74 systematically reviewed current randomized evidence on first-line treatments for controlling seizures in adults with convulsive status epilepticus before or at hospital arrival. 38 examined the effects of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures. 22 investigated the use of pregabalin as add-on therapy for drug-resistant partial epilepsy. 9 explored whether treating the first tonic-clonic seizure improves the prognosis of epilepsy. 39 reviewed psychological and behavioral treatments for adults with non-epileptic attack disorder. compared the impact of two different therapeutic strategies: early add-on treatment versus alternative monotherapy in patients with partial seizures intractable to the first prescribed antiepileptic drug. 35 investigated the potential of melatonin as add-on treatment for epilepsy. 64 reported on a randomized controlled trial of bumetanide to treat neonatal seizures. 34 presented a randomized clinical trial comparing progesterone treatment with placebo therapy for women with partial epilepsy. 73 reported a randomized clinical trial comparing the treatment effects of clinical seizures versus electrographic seizures in full-term and near-term neonates. 75 synthesized evidence on pre-hospital and emergency department treatment of convulsive status epilepticus in adults. 17 reviewed anticonvulsants for neonates with seizures. 19 examined the efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. 77 reported on a randomized clinical trial investigating the efficacy and safety of fenfluramine for treating seizures associated with Lennox-Gastaut syndrome. 51 explored the influence of anticonvulsive treatment on neuropsychological performance in children with BECTS. 13 evaluated the impact of topiramate on ictal seizure semiology. 31 reported the long-term follow-up of a randomized clinical trial demonstrating that treatment of the first tonic-clonic seizure did not affect mortality. 16 reported on a trial of antiparasitic treatment to reduce seizure rates due to cerebral cysticercosis. 47 investigated the potential of melatonin as add-on treatment for epilepsy. 53 conducted a systematic review and meta-analysis of seizure outcomes after occipital lobe and posterior quadrant epilepsy surgery. 63 systematically reviewed the efficacy of levetiracetam in neonatal seizures. 82 reported on a Phase 2b randomized clinical trial evaluating the efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy. 15 explored the use of zonisamide as add-on treatment for drug-resistant partial epilepsy. 55 examined surgery for drug-resistant epilepsy in children. 71 conducted a network meta-analysis comparing the efficacy of anti-epileptic drugs for neonatal seizures. 11 compared the effects of rectal diazepam gel with placebo for acute repetitive seizures. 54 conducted a network meta-analysis of individual participant data on antiepileptic drug monotherapy for epilepsy. 43 explored the potential of clobazam monotherapy for treating new partial-onset or generalized-onset seizures. 28 investigated the rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with refractory partial seizures. 58 conducted a systematic review and meta-analysis of quality of life after epilepsy surgery in children. 67 reported on a placebo-controlled randomized clinical trial evaluating add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex. 52 conducted an individual participant data review comparing topiramate versus carbamazepine monotherapy for epilepsy. 60 explored the use of lamotrigine add-on therapy for drug-resistant focal epilepsy. 1 investigated the use of phenytoin as monotherapy for epilepsy. 27 systematically reviewed the management of prolonged seizures and status epilepticus in childhood. 37 conducted a meta-analysis evaluating the clinical efficacy and safety of newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy. 29 discussed treatment for seizures in multiple sclerosis. 41 reported on a multicenter pilot treatment trial for psychogenic nonepileptic seizures (a randomized clinical trial). 45 examined subpial transection surgery for epilepsy. 57 conducted a systematic review with network meta-analysis of randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures.

Treatment Summary

Seizures can be treated through various approaches, including medication, surgery, and psychotherapy. 74 recommends benzodiazepines as a first-line treatment for convulsive status epilepticus in adults. 38 suggests that cognitive behavioral therapy may be effective for treating psychogenic nonepileptic seizures. 22 suggests that pregabalin may be effective as add-on therapy for drug-resistant partial epilepsy. 9 suggests that carbamazepine, phenytoin, phenobarbital, or sodium valproate may be effective treatments for the first tonic-clonic seizure. 39 suggests that cognitive behavioral therapy, hypnotherapy, and paradoxical therapy may be effective psychotherapies for adults with non-epileptic attack disorder. suggests that several effective treatment options exist for early add-on therapy in patients with partial epilepsy. 35 suggests that melatonin may be effective as add-on treatment for epilepsy. 64 suggests that bumetanide may be effective for treating neonatal seizures. 34 suggests that progesterone treatment may be effective for women with partial epilepsy. 73 suggests that treating electrographic seizures is important for managing seizures in neonates. 75 recommends benzodiazepines as a first-line treatment for convulsive status epilepticus in pre-hospital and emergency department settings. 17 suggests that the effectiveness of anticonvulsants for neonates with seizures requires evaluation. 19 suggests that carbamazepine and valproate may be effective monotherapies for early epilepsy and single seizures. 77 suggests that fenfluramine may be an effective treatment for seizures associated with Lennox-Gastaut syndrome. 51 suggests that the effectiveness of anticonvulsive treatment for children with BECTS requires further investigation. 13 suggests that topiramate may impact ictal seizure semiology. 31 suggests that treatment of the first tonic-clonic seizure does not affect mortality. 16 suggests that antiparasitic treatment may be effective for reducing seizure rates due to cerebral cysticercosis. 47 suggests that melatonin may be effective as add-on treatment for epilepsy. 53 suggests that surgery may be an effective treatment for occipital lobe and posterior quadrant epilepsy. 63 suggests that levetiracetam may be an effective treatment for neonatal seizures. 82 suggests that XEN1101, a novel potassium channel opener, may be an effective treatment for focal epilepsy. 15 suggests that zonisamide may be effective as add-on treatment for drug-resistant partial epilepsy. 55 suggests that surgery may be an effective treatment for drug-resistant epilepsy in children. 71 suggests that various antiepileptic drugs may be effective for treating neonatal seizures. 11 suggests that rectal diazepam gel may be effective for treating acute repetitive seizures. 54 suggests that various antiepileptic drugs may be effective for treating epilepsy. 43 suggests that clobazam monotherapy may be effective for treating new partial-onset or generalized-onset seizures. 28 suggests that pregabalin may be effective as add-on treatment for patients with refractory partial seizures. 58 suggests that epilepsy surgery may be effective for improving quality of life in children. 67 suggests that cannabidiol may be an effective treatment for drug-resistant seizures in tuberous sclerosis complex. 52 suggests that topiramate and carbamazepine may be effective treatments for epilepsy. 60 suggests that lamotrigine may be an effective treatment for drug-resistant focal epilepsy. 1 suggests that phenytoin may be an effective treatment for epilepsy. 27 suggests that various treatment options may be effective for managing prolonged seizures and status epilepticus in childhood. 37 suggests that newer antiepileptic drugs may be effective as adjunctive treatment for adults with refractory partial-onset epilepsy. 29 suggests that various treatment options may be effective for treating seizures in multiple sclerosis. 41 suggests that various treatment options may be effective for treating psychogenic nonepileptic seizures. 45 suggests that subpial transection surgery may be an effective treatment for epilepsy. 57 suggests that various antiepileptic drugs may be effective for treating post-stroke seizures.

Benefits and Risks

Benefit Summary

Treating seizures can reduce the frequency and severity of seizures and improve quality of life. 9 suggests that treatment for the first tonic-clonic seizure can reduce the risk of future seizures. 39 suggests that psychotherapy for adults with non-epileptic attack disorder can reduce seizure frequency and improve quality of life. 73 suggests that treating electrographic seizures is crucial for managing seizures in neonates. 75 recommends benzodiazepines as a first-line treatment for convulsive status epilepticus in pre-hospital and emergency department settings. 58 suggests that epilepsy surgery can improve quality of life for children.

Risk Summary

Treating seizures carries the risk of side effects. 9 reports side effects of antiepileptic drugs, including drowsiness, dizziness, and unsteadiness. 39 reports that psychotherapy can have side effects like anxiety and depression. 35 reports side effects of melatonin, including drowsiness, headache, and digestive issues. 71 reports that antiepileptic drugs used to treat neonatal seizures can cause neurodevelopmental delays. 67 reports side effects of cannabidiol, including drowsiness, increased appetite, and fatigue. 60 reports side effects of lamotrigine, including dizziness, unsteadiness, and rash. 1 reports side effects of phenytoin, including gingival hyperplasia and liver function abnormalities. 45 reports that subpial transection surgery for epilepsy can cause cognitive impairment.

Comparison Between Studies

Commonalities

Many studies evaluate the effectiveness of treatments for reducing seizures. They also suggest that treatment comes with the risk of side effects.

Differences

These studies differ in their focus on specific seizure types, treatment methods, and evaluation approaches. Direct comparisons of their findings can be challenging.

Consistency and Contradictions in Results

Research findings on seizure treatment can be consistent or contradictory. For example, 9 suggests that treating the first tonic-clonic seizure can reduce the risk of future seizures, while 31 suggests that treating the first tonic-clonic seizure does not affect mortality. These contradictions are likely due to differences in the patient populations, treatment methods, and research designs.

Considerations for Real-World Applications

While these research findings provide valuable information about seizure treatment options, it's essential to consult with a doctor to determine the best treatment approach for each individual. Doctors will consider factors like the type of seizure, seizure frequency and severity, age, and other health conditions to personalize treatment plans.

Limitations of Current Research

Research on seizure treatment is still incomplete. Long-term effects and side effects, in particular, require more investigation. Many studies focus on specific seizure types or specific treatments, limiting their generalizability to all patients.

Future Research Directions

Future research on seizure treatment should focus on evaluating long-term effects, side effects, and the effectiveness of different treatments for diverse seizure types. Patient-centered research and meta-analyses integrating findings from multiple studies are also crucial.

Conclusion

Seizures can be treated effectively through medication, surgery, and psychotherapy. These treatments have the potential to reduce seizure frequency and severity and improve quality of life, but they also come with the risk of side effects. It is crucial to consult with a doctor to determine the most appropriate treatment plan for each individual. Continued research on long-term effects, side effects, and the effectiveness of various treatment options is needed to refine and improve seizure management practices.

Treatment List

Medication: benzodiazepines, carbamazepine, phenytoin, phenobarbital, valproic acid, pregabalin, melatonin, bumetanide, progesterone, levetiracetam, zonisamide, clobazam, topiramate, lamotrigine, fenfluramine, cannabidiol

Surgery: subpial transection surgery

Psychotherapy: cognitive behavioral therapy, hypnotherapy, paradoxical therapy


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 82 papers
Positive Content
73
Neutral Content
3
Negative Content
6
Article Type
35
18
45
33
82

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : German


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.